{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:53:12Z","timestamp":1793321592153,"version":"4.5.0"},"reference-count":38,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"unspecified","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2021,11,9]]},"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>Continuous glucose monitoring (CGM)-derived time in range (TIR) correlates with hemoglobin A1c (A1c) among patients with type 2 diabetes mellitus (T2DM); however, there is a paucity of data evaluating its association with microvascular complications. We conducted this systematic review to examine the association between TIR and microvascular complications of diabetic retinopathy (DR), diabetic nephropathy (DN), and diabetic peripheral neuropathy (DPN). We conducted a comprehensive literature search on PubMed, Scopus, and Web of Science online databases following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Full-text original articles that evaluated the association between CGM-derived TIR and risk of microvascular complications and were published between 2010 and June 2021 were included in our systematic review. The quality of the included studies was evaluated using the National Heart, Lung, and Blood Institute Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies. Data were analyzed using qualitative synthesis. Eleven studies on a total of 13\u2009987 patients were included in the systematic review. The median sample size, baseline A1c, and diabetes duration were 466 patients (range: 105\u20135901), 8.2% (SD 0.5%), and 11.3 years (1.0), respectively. Majority of the studies were conducted in Asia (10 out of 11). Four studies evaluated the relationship between CGM-derived TIR and DR and CGM-derived TIR and DN, while seven studies evaluated the relationship between CGM-derived TIR and DPN. A 10% increase in TIR was associated with a reduction in albuminuria, severity of DR, and prevalence of DPN and cardiac autonomic neuropathy. In addition, an association was observed between urinary albumin to creatinine ratio but not with estimated glomerular filtration rate. This review summarizes recent evidence supporting an association between CGM-derived TIR and microvascular complications among patients with T2DM. A larger-scale multicenter investigation that includes more diverse participants is warranted to further validate the utility of TIR as a predictor of diabetic microvascular complications.<\/jats:p>","DOI":"10.1136\/bmjdrc-2021-002573","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T20:25:34Z","timestamp":1641241534000},"page":"e002573","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":96,"title":["Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: a systematic review"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4151-3246","authenticated-orcid":false,"given":"Rishi","family":"Raj","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Diabetes, and Metabolism, Pikeville Medical Center, Pikeville, Kentucky, USA"},{"name":"Department of Internal Medicine, University of Pikeville Kentucky College of Osteopathic Medicine, Pikeville, Kentucky, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Mishra","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Maulana Azad Medical College, New Delhi, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9217-542X","authenticated-orcid":false,"given":"Nivedita","family":"Jha","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Adichunchanagiri Institute of Medical Sciences, Mandya, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0369-9502","authenticated-orcid":false,"given":"Vivek","family":"Joshi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Drexel University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2761-2907","authenticated-orcid":false,"given":"Ricardo","family":"Correa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Diabetes, and Metabolism, The University of Arizona College of Medicine - Phoenix, Phoenix, Arizona, USA"},{"name":"Department of Internal Medicine, Division of Endocrinology, Diabetes, and Metabolism, Phoenix VA Medical Center, Phoenix, Arizona, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4761-7417","authenticated-orcid":false,"given":"Philip A","family":"Kern","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Kentucky College of Medicine, Lexington, Kentucky, USA"},{"name":"Barnstable Brown Diabetes Center, University of Kentucky, Lexington, Kentucky, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,1,3]]},"reference":[{"key":"2025073112182148000_10.1.e002573.1","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1144"},{"key":"2025073112182148000_10.1.e002573.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7258.405"},{"key":"2025073112182148000_10.1.e002573.3","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-0636"},{"key":"2025073112182148000_10.1.e002573.4","doi-asserted-by":"publisher","DOI":"10.2337\/dci19-0028"},{"key":"2025073112182148000_10.1.e002573.5","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1581"},{"key":"2025073112182148000_10.1.e002573.6","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1600"},{"key":"2025073112182148000_10.1.e002573.7","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1444"},{"key":"2025073112182148000_10.1.e002573.8","doi-asserted-by":"publisher","DOI":"10.2337\/dci18-0040"},{"key":"2025073112182148000_10.1.e002573.9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/8879085","article-title":"The correlation between time in range and diabetic microvascular complications utilizing information management platform","volume":"2020","author":"Sheng","year":"2020","journal-title":"Int J Endocrinol"},{"key":"2025073112182148000_10.1.e002573.10","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-4-200908180-00135"},{"key":"2025073112182148000_10.1.e002573.11","unstructured":"Study quality assessment tools | NHLBI, NIH, 2021. Available: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/"},{"key":"2025073112182148000_10.1.e002573.12","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1131"},{"key":"2025073112182148000_10.1.e002573.13","first-page":"1","article-title":"Time in range, as a novel metric of glycemic control, is reversely associated with presence of diabetic cardiovascular autonomic neuropathy independent of HbA1c in Chinese type 2 diabetes","volume":"2020","author":"Guo","year":"2020","journal-title":"J Diabetes Res"},{"key":"2025073112182148000_10.1.e002573.14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4239\/wjd.v11.i11.489","article-title":"Continuous glucose monitoring defined time-in-range is associated with sudomotor dysfunction in type 2 diabetes","volume":"11","author":"Guo","year":"2020","journal-title":"World J Diabetes"},{"key":"2025073112182148000_10.1.e002573.15","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108289","article-title":"Tir generated by continuous glucose monitoring is associated with peripheral nerve function in type 2 diabetes","volume":"166","author":"Li","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"2025073112182148000_10.1.e002573.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-000991"},{"key":"2025073112182148000_10.1.e002573.17","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1089\/dia.2019.0499","article-title":"Association between continuous glucose Monitoring-Derived time in range, other core metrics, and albuminuria in type 2 diabetes","volume":"22","author":"Yoo","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"2025073112182148000_10.1.e002573.18","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1089\/dia.2020.0599","article-title":"The association between continuous glucose Monitoring-Derived metrics and cardiovascular autonomic neuropathy in outpatients with type 2 diabetes","volume":"23","author":"Kim","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"2025073112182148000_10.1.e002573.19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/dia.2020.0672","article-title":"Profiles of Intraday glucose in type 2 diabetes and their association with complications: an analysis of continuous glucose monitoring data","volume":"23","author":"Varghese","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"2025073112182148000_10.1.e002573.20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001923"},{"key":"2025073112182148000_10.1.e002573.21","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/jdi.13394","article-title":"Association of time in range, as assessed by continuous glucose monitoring, with painful diabetic polyneuropathy","volume":"12","author":"Yang","year":"2021","journal-title":"J Diabetes Investig"},{"key":"2025073112182148000_10.1.e002573.22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/jdi.13336","article-title":"Relationships between time in range, glycemic variability including hypoglycemia and types of diabetes therapy in Japanese patients with type 2 diabetes mellitus: Hyogo diabetes hypoglycemia cognition complications study","volume":"12","author":"Kuroda","year":"2021","journal-title":"J Diabetes Investig"},{"key":"2025073112182148000_10.1.e002573.23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13340-018-0345-3","article-title":"Japanese clinical practice guideline for diabetes 2016","volume":"9","author":"Haneda","year":"2018","journal-title":"Diabetol Int"},{"key":"2025073112182148000_10.1.e002573.24","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.10.1.1"},{"key":"2025073112182148000_10.1.e002573.25","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00092.x"},{"key":"2025073112182148000_10.1.e002573.26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/1479164118756240","article-title":"Accuracy of flash glucose monitoring and continuous glucose monitoring technologies: implications for clinical practice","volume":"15","author":"Ajjan","year":"2018","journal-title":"Diab Vasc Dis Res"},{"key":"2025073112182148000_10.1.e002573.27","doi-asserted-by":"crossref","first-page":"S-25","DOI":"10.1089\/dia.2017.0035","article-title":"Continuous glucose monitoring: a review of recent studies demonstrating improved glycemic outcomes","volume":"19","author":"Rodbard","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"2025073112182148000_10.1.e002573.28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/dia.2018.0310","article-title":"The relationship of hemoglobin A1c to Time-in-Range in patients with diabetes","volume":"21","author":"Vigersky","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"2025073112182148000_10.1.e002573.29","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/1932296818822496","article-title":"The relationships between time in range, hyperglycemia metrics, and HbA1c","volume":"13","author":"Beck","year":"2019","journal-title":"J Diabetes Sci Technol"},{"key":"2025073112182148000_10.1.e002573.30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1089\/dia.2019.0251","article-title":"Time in range is associated with carotid intima-media thickness in type 2 diabetes","volume":"22","author":"Lu","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"2025073112182148000_10.1.e002573.31","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0909"},{"key":"2025073112182148000_10.1.e002573.32","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.14.1707"},{"key":"2025073112182148000_10.1.e002573.33","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.11.2795"},{"key":"2025073112182148000_10.1.e002573.34","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1304-0"},{"key":"2025073112182148000_10.1.e002573.35","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-018-0677-0","article-title":"Long-Term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study","volume":"17","author":"Cardoso","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"2025073112182148000_10.1.e002573.36","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","article-title":"Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes","volume":"295","author":"Monnier","year":"2006","journal-title":"JAMA"},{"key":"2025073112182148000_10.1.e002573.37","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-0864"},{"key":"2025073112182148000_10.1.e002573.38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1515\/labmed-2019-0189","article-title":"Basics and use of continuous glucose monitoring (CGM) in diabetes therapy","volume":"44","author":"Freckmann","year":"2020","journal-title":"J Lab Med"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2021-002573","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T19:18:28Z","timestamp":1753989508000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2021-002573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,3]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1136\/bmjdrc-2021-002573"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2021-002573","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.08.27.21262743","asserted-by":"object"}]},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}